Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
2024 AUA/Urology Care Foundation Research Honors Program
The Urology Care Foundation Research Honors Program is held annually at the AUA Annual Meeting to recognize the outstanding achievements of the Foundation's funded investigators who are completing their research projects, acknowledge the newest research awardees and present the special Awards of Distinction. The AUA and its Urology Care Foundation celebrated these talented individuals and acknowledged their commitment to urologic research at the 2024 Research Honors Program & Reception on May 4, 2024.
We are excited to present a special online publication featuring their hard work and commitment to advancing urology through research. Within these pages you’ll find:
- Introduction from the Urology Care Foundation and AUA Research Council
- Acceptance Notes from the 2024 Research Awardees of Distinction
- Celebration of our Graduating Research Awardees
- Recognition of New and Currently-Funded Researchers
- Special Thanks for Exemplary Service to the AUA Research Council and Committees
Dates to Remember
April 1, 2024 –December 2, 2024
- 2024 MVP registration window.
- To register, sign into the QPP website with your HCQIS Access and Roles Profile (HARP) account. **A HARP account is required to complete registration.**
October 3, 2024
- Last day to start a 90-day performance period for Improvement Activities.
October 31, 2024
- Data Release Consent Forms (DRCF) are available via the AQUA Registry dashboard.
- Last day to submit measure refinements for 2024 selected measures.
*Submissions are not allowed at this point.
advertisement
advertisement